Zeltiq Aesthetics Inc (ZLTQ) is Initiated by Brean Capital to Buy

Zeltiq Aesthetics Inc (ZLTQ) was Initiated by Brean Capital to “Buy”. Brean Capital advised their investors in a research report released on Apr 13, 2016.

Many Wall Street Analysts have commented on Zeltiq Aesthetics Inc. Shares were Reiterated by Maxim Group on Mar 1, 2016 to “Buy” and Lowered the Price Target to $ 40 from a previous price target of $50 .Zeltiq Aesthetics Inc was Upgraded by Griffin Securities to ” Buy” on Jan 22, 2016.

On the company’s financial health, Zeltiq Aesthetics Inc reported $0.99 EPS for the quarter, beating the analyst consensus estimate by $ 0.88 according to the earnings call on Feb 29, 2016. Analyst had a consensus of $0.11. The company had revenue of $78.23 million for the quarter, compared to analysts expectations of $77.30 million. The company’s revenue was up 54.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.03 EPS.

Zeltiq Aesthetics Inc closed down -0.64 points or -2.24% at $27.94 with 4,17,190 shares getting traded on Monday. Post opening the session at $28.62, the shares hit an intraday low of $27.86 and an intraday high of $29.2 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

In a different news, on Mar 23, 2016, Mark J Foley (President and CEO) sold 9,698 shares at $25.01 per share price. According to the SEC, on Dec 9, 2015, Andrew N Schiff (director) sold 32,782 shares at $30.09 per share price. On Dec 8, 2015, Mary Fisher (director) sold 30,000 shares at $30.09 per share price, according to the Form-4 filing with the securities and exchange commission.

ZELTIQ Aesthetics Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product the CoolSculpting System is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells which are needed to perform procedures using its CoolSculpting system. As of December 31 2014 it had an installed base of 3176 CoolSculpting systems installed across approximately 2688 practices across the world. As of December 31 2014 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Zeltiq Aesthetics Inc

Leave a Reply

Zeltiq Aesthetics Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zeltiq Aesthetics Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.